Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EXTEND Trial: Fixed-extended-duration Antibiotics (28 Days) Compared to Standard Care Antibiotic Durations in Adult Patients With Complicated Intra-abdominal Infection and Their Impact on Treatment Failure

NCT05148702 is registered in ClinicalTrials.gov with Lydia Flett as lead sponsor.

NCT NCT05148702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05148702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EXTEND Trial: Fixed-extended-duration Antibiotics (28 Days) Compared to Standard Care Antibiotic Durations in Adult Patients With Complicated Intra-abdominal Infection and Their Impact on Treatment Failure
Lead sponsor
Lydia Flett
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 10, 2022
Completion date
July 31, 2026
Enrollment
1,166 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

complicated intra-abdominal infection